Providers on the topic

With around 6,000 European companies operating in India and an annual trade of 180 billion euros between the EU and India at present, the trade deal intends to double EU goods exports to India by 2032. (Source: © NazeerArt - stock.adobe.com)
EU-India Free Trade Agreement

Tariff Breakthrough: How the EU–India Pact Reshapes Chemicals and Pharma Trade

The EU-India free trade agreement is expected to double EU goods exports to India by 2032. With a specific focus on the chemicals and pharmaceuticals industries, the trade deal highlights that India will eliminate current tariffs of up to 22 % on EU chemicals and 11 % on EU pharmaceuticals while the EU will also cut tariffs to zero on Indian chemical exports as well as offer Indian pharmaceutical and medical devices companies’ preferential access to the EU market. In this scenario, what do industry leaders in the chemical and pharma space have to say about the EU-India free trade deal? Read on to find out…

Read on

Galleries

Escalating production expenses, surging energy costs, subdued demand, and waning investments leave no doubt – the European chemical industry is in a crisis.  (Source: © Grispb - stock.adobe.com)
Market Scenario

Europe’s Chemical Industry in Crisis

Europe’s chemical industry is sliding into crisis as rising energy costs, weak demand, and dwindling investments force widespread plant shutdowns. Without swift policy intervention, the region risks losing its industrial backbone to competitors in lower cost, faster growing markets.

Read on